Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi MSD (SPM) (manufacturer control number: 2016007078), as a part of a business agreement, on 06-JUL-2016. Case received from a physician via HA with reference number DK-DKMA-WBS-0003936 on 05-JUL-2016. A 12-year-old female adolescent patient received GARDASIL, (batch number is not available, Dose -1) via intramuscular route on 30-AUG-2011. The patient experienced headache, nausea, sweating tendency, pain in hip, abdominal pain, concentration impairment and epilepsy on an unknown date. History Around Side Effects: 17 year old girl with diffuse and intrusive symptoms, the headaches, nausea, sweating, hip pain and abdominal pain have been the most dominating ones. The patient via neurologists started treatment for suspected epilepsy. She is also under investigation in child psychiatry on suspicion of OCD. There is a strong history of psychiatric disorder in the form of among other things affective disorder and ADD. Derived therefrom also significant psychosocial stress. It''s hard to get a clear overview of when symptoms began in connection with HPV vaccine. Presumably, some of the symptoms been present before vaccination. The patient had a medical history of: -Affective disorder, -Attention deficit/hyperactivity disorder, -Obsessive-compulsive disorder. The patient''s outcome was reported as not recovered/not resolved.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166